首页> 美国卫生研究院文献>other >Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia
【2h】

Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia

机译:妊娠合并严重先兆子痫中铜蓝蛋白的胎盘表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is consensus that ischemia/reperfusion injury associated with preeclampsia (PE) promotes both placental damage and the release of factors leading to maternal endothelium dysfunction, a hallmark of this potentially life-threatening syndrome. These factors include plasminogen activator inhibitor-1 (PAI-1) and soluble fms-like tyrosine kinase-1 (sFlt-1). The goal of this study was to further characterize placental factors involved in the pathophysiology of PE. Thus, DNA microarray gene profiling was utilized to identify mRNA differentially regulated in placentas from women with severe PE compared to both preterm (PC) and term control (TC) groups. Microarray studies detected an upregulation of mRNA for ceruloplasmin, a copper-containing iron transport protein with antioxidant ferroxidase properties, in PE compared to PC and TC placentas, respectively. Quantitative real-time PCR confirmed these results by demonstrating significant increases in ceruloplasmin mRNA in PE vs PC and TC placentas. Supporting previous reports, the expression of sFlt-1 and PAI-1 were also upregulated in PE placentas. Immunohistochemistry localized ceruloplasmin to the intervillous space in PE and PC placentas, whereas stronger syncytial staining was noted in PE. Western blotting confirmed a significant increase in ceruloplasmin levels in placental tissue in PE compared to PC groups. PCR identified the presence of mRNA for ceruloplasmin in primary cultures of syncytiotrophoblasts, but not villous-derived fibroblasts, suggesting that syncytium is the site of ceruloplasmin synthesis in placenta. Hypoxic treatment (1% O2) of syncytiotrophoblasts enhanced levels of ceruloplasmin mRNA approximately 25-fold, a significantly greater upregulation than that noted for PAI-1 and sFlt-1, suggesting that enhanced ceruloplasmin expression is a sensitive marker of syncytial hypoxia. We suggest that syncytial ceruloplasmin and its associated ferroxidase activity, induced by the hypoxia accompanying severe PE, is important in an endogenous cellular program to mitigate the damaging effects of subsequent reperfusion injury at this site.
机译:人们普遍认为,与先兆子痫(PE)相关的缺血/再灌注损伤会促进胎盘损伤和导致孕产妇内皮功能障碍的因子的释放,这是这种潜在威胁生命的综合征的标志。这些因素包括纤溶酶原激活物抑制剂1(PAI-1)和可溶性fms样酪氨酸激酶1(sFlt-1)。这项研究的目的是进一步表征参与PE病理生理的胎盘因子。因此,与早产(PC)组和足月对照组(TC)组相比,DNA微阵列基因谱分析可用于鉴定患有严重PE的妇女在胎盘中差异调节的mRNA。微阵列研究发现,与PC和TC胎盘相比,PE中的铜蓝蛋白(一种具有抗氧化铁氧化酶特性的含铜铁转运蛋白)的mRNA上调。实时定量PCR证实了PE与PC和TC胎盘中铜蓝蛋白mRNA的显着增加,证实了这些结果。支持先前的报道,PE胎盘中sFlt-1和PAI-1的表达也上调。免疫组织化学法将铜蓝蛋白定位于PE和PC胎盘的绒毛间隙,而PE中的合胞体染色更强。 Western印迹证实与PC组相比,PE胎盘组织中的铜蓝蛋白水平显着增加。 PCR鉴定了合胞体滋养层细胞的原代培养物中铜蓝蛋白的mRNA的存在,但绒毛来源的成纤维细胞却没有,表明合胞体是胎盘中铜蓝蛋白的合成位点。缺氧处理(1%O2)合体滋养层细胞可将铜蓝蛋白mRNA的水平提高约25倍,比PAI-1和sFlt-1明显升高,表明铜蓝蛋白表达增强是合体性缺氧的敏感标志。我们建议,由严重的PE伴随的缺氧引起的合胞性铜蓝蛋白及其相关的亚铁氧化酶活性在内源性细胞程序中减轻在该部位随后的再灌注损伤的破坏作用中很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号